Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF | V.TLT.WT

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > IBRX Crashes as FDA issues CRL

<< Previous

Bullboard Posts

Next >>

Comment by DJDawgon May 11, 2023 9:21am

137 Views

Post# 35442781

RE:IBRX Crashes as FDA issues CRL

Sorry for the IBRX investors. We have all been there.

One thing I will say is that the huge pre-market price drop on this specific news and a similar process with SESN when it lost all value suggests that, with publicity, the market considers a NMIBC treatment very valuable. IBRX is down more the 1B in market cap pre-market just for this specific failure.

<< Previous

Bullboard Posts

Next >>

Volatus Aerospace expands oil and gas surveillance into the U.S.